Brief: Natera Q2 EPS USD -0.47
06/08/2026 21:06
BRIEF-Natera Q2 EPS USD -0.47 Aug 06 (Reuters) - Natera Q2 revenue USD 752.8 million vs. IBES estimate USD 660.7 million.
- Q2 income from operations USD -75.8 million
- Q2 operating expenses USD 555.3 million
- Q2 net income USD -67 million
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers